Concepedia

Publication | Open Access

Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML

58

Citations

19

References

2013

Year

References

YearCitations

Page 1